MedPath

IMPACT: Does the absolute magnitude of Platelet Inhibition inversely correlates with the number of TCD-detected microemboli during and after CAS in asymptomatic patients undergoing carotid artery stenting prior to cardiac surgery who are being pre-treated with either a 300 mg or a 600 mg loading dose of clopidogrel?

Phase 2
Conditions
carodit stenosis
10007963
10003216
Registration Number
NL-OMON31555
Lead Sponsor
R&D Cardiologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

-patient > 18 years of age
-patient accepted for CABG and CAS
-temporal window for TCD available

Exclusion Criteria

-severe renal impairment, abnormal liver function, malignancy, febrile disorder, acute or chronic inflammatory disease and other diseases influencing platelet reactivity
-extreme tortuositas or calcification of the lesion
-patients with active bleeding or at high-risk of bleeding
-uncontrolled hypertension ( > 180/110 mmHg)despite optimal medication

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath